SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jules who wrote (1915)2/23/1999 2:35:00 PM
From: Steve Harmon  Read Replies (1) of 2742
 
The extra cash from Techne puts CISTRON's total cash at 58 cent a share. Companies are paying 20-30% premium for cash. Cistron should get an absolute minimum of 80 cent a share when they sell for JUST their cash.

That gives the buyer the $30 million PMC deal for FREE.

Of course in the past whenever CIST gets more cash their stock price goes lower. Shareholders are DE-hanced!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News